Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Patupilone

Generic Name: Patupilone

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₄₁NO_₆S

CAS Number: 152044-54-7

Unique Ingredient Identifier: UEC0H0URSE

Overview

Epothilone B is a 16-membered macrolide that mimics the biological effects of taxol.

Background

Epothilone B is a 16-membered macrolide that mimics the biological effects of taxol.

Indication

Investigated for use/treatment in ovarian cancer, lung cancer, brain cancer, breast cancer, and gastric cancer.

Associated Conditions

No associated conditions information available.

Clinical Trials

Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma

Phase 1

Completed

Posted: 2008/07/14

Sponsor:University of Zurich

ID:NCT00715013

Phase I Study of Patupilone and RAD001

Phase 1

Completed

Posted: 2007/07/04

Sponsor:University of Medici...

ID:NCT00496600

The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Phase 1

Terminated

Posted: 2007/05/02

Sponsor:Novartis Pharmaceuti...

ID:NCT00468260

Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Phase 1

Completed

Posted: 2007/03/16

Sponsor:Novartis Pharmaceuti...

ID:NCT00448396

Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)

Phase 1

Withdrawn

Posted: 2007/03/02

Sponsor:Novartis Pharmaceuti...

ID:NCT00442741

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy